Merck Tbk. vs Surya Semesta Internusa Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Surya Semesta Internusa Tbk. trades at Rp1,780 (market cap 7.25T, 89.17M 24h volume). The key difference: Surya Semesta Internusa Tbk. is far larger — about 4.3× Merck Tbk.'s market cap, and Surya Semesta Internusa Tbk. is more actively traded (89.17M versus 37.6K). Which is the better fit depends on your goals.
| MERK | SSIA | |
|---|---|---|
Market Cap | 1.7T | 7.25T |
Volume | 37.6K | 89.17M |
Lot | 376 | 891.65K |
Turnover | 144.47M | 154.58B |
Average Price | 3,842.23 | 1,733.63 |
Value | 144.47M | 154.58B |
Indicative Equilibrium Price | 3,840 | 1,780 |
Indicative Equilibrium Volume | 7 | 19.08K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT. Surya Semesta Internusa Tbk (formerly known as PT. Multi Investment Ltd.) was established based on notarial deed No. 37 dated June 15, 1971 of Umi Sutamto, S.H., notary in Jakarta. It is a publicly-listed company engaged in investment in the shares of subsidiaries that develop and manage industrial and real estate, provide construction services, manufacture and market pre-cast and pre-stressed concrete and own hotels.
Read more on SSIA →